Skip to main content
OpenTrials
Completed

NCT Number: NCT04376086

Segmental Epidural Block for Feeding Jeujunostomy in Cancer Patients

This study aim is to compare the efficiency and safety of segmental epidural block versus general anesthesia in cancer patients undergoing surgical feeding jejunostomy

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

National Cancer Institute

Cairo, 11796, Egypt

About this study

Comparing general anesthesia versus segmental epidural anesthesia in feeding jejunostomy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients scheduled for surgical feeding jejunostomy more than 18 years old

Exclusion criteria

  • patien refusal Coagulation defect Abnormal kidney or liver functions Local infection at site of block Bone metastases

Treatment and study plan

epidural anesthesia

Procedure

Segmental epidural analgesia

General Anesthesia

Procedure

general anesthesia

Primary outcomes

  1. Analgesic requirements

    Time frame: first 24 hours

    Analgesic requirments

  2. Haemodynamics

    Time frame: periooperative time

    blood pressure

Secondary outcomes

  1. VAS score

    Time frame: 24 hours

    visual analouge scale 0 minimum to 10 maximum score

Sponsors and collaborators

Lead sponsor

National Cancer Institute, Egypt

Other

Registry information

Official study title

Segmental Epidural Block for Feeding Jejunostomy in Cancer Patients

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
May 6, 2020
Registry last updated
May 7, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.